| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 8 | |
| #2 | United States | 6 | |
| #3 | WIPO (World Intellectual Property Organization) | 5 | |
| #4 | Australia | 4 | |
| #5 | Brazil | 3 | |
| #6 | Canada | 3 | |
| #7 | Israel | 3 | |
| #8 | China | 2 | |
| #9 | Japan | 1 | |
| #10 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Measurement | |
| #4 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Sugars | |
| #4 | Peptides | |
| #5 | Analysing materials | |
| #6 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Gengrinovitch Stela | 30 |
| #2 | Ben Yakar Ruth | 10 |
| #3 | Izakovich Esther | 4 |
| #4 | Stela Gengrinovitch | 4 |
| #5 | Flaishon Liat | 4 |
| #6 | Tessler Shoshi | 4 |
| #7 | Ruth Ben Yakar | 3 |
| #8 | Liat Flaishon | 1 |
| #9 | Shoshi Tessler | 1 |
| Publication | Filing date | Title |
|---|---|---|
| BR112020000492A2 | combination cancer therapy | |
| WO2017094011A1 | Salts of conjugates for cancer therapy | |
| AU2016362239A1 | Salts of conjugates for cancer therapy | |
| CA3007058A1 | Cytarabine conjugates for cancer therapy | |
| IL183334D0 | Activated labeling reagents and methods for preparing and using the same | |
| WO2006054310A1 | Activated labeling reagents and methods for preparing and using the same | |
| WO2005072061A2 | Conjugates for cancer therapy and diagnosis | |
| AU2001288025A8 | Peptide conjugated anti-cancer prodrugs |